Logotype for Equillium Inc

Equillium (EQ) investor relations material

Equillium Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Equillium Inc
Q3 2025 earnings summary13 Nov, 2025

Executive summary

  • Focused on developing novel therapies for autoimmune and inflammatory disorders, with EQ504 as the lead candidate advancing toward clinical development and Phase 1 study planned for mid-2026.

  • Completed a $30 million private placement in August 2025, with potential for an additional $20 million upon achieving clinical and pricing milestones, funding operations through 2027.

  • Terminated the Biocon collaboration and license agreement, reverting rights to itolizumab to Biocon.

  • Hosted a key opinion leader event highlighting the clinical potential of EQ504 and AhR modulation in immune-mediated diseases.

  • Accumulated deficit reached $212.4 million as of September 30, 2025.

Financial highlights

  • Cash and cash equivalents were $33.1 million as of September 30, 2025, up from $18.1 million at December 31, 2024.

  • Net loss for the nine months ended September 30, 2025 was $18.6 million, while Q3 2025 net loss was $4.2 million, reflecting the absence of revenue and reduced expenses.

  • No revenue recognized in Q3 2025; prior year revenue was $12.2 million for the quarter and $36.7 million for the nine months, all from now-terminated agreements.

  • Research and development expenses decreased to $1.3 million in Q3 2025 from $9.6 million in Q3 2024, reflecting the wind-down of clinical studies.

  • General and administrative expenses were $3.3 million in Q3 2025, flat year-over-year.

Outlook and guidance

  • Cash runway expected to fund operations through 2027, assuming current plans and estimates.

  • Phase 1 proof-of-mechanism study for EQ504 planned to commence by mid-2026, with data expected approximately six months later.

  • No product sales or milestone revenue expected in the next 12 months.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Equillium earnings date

Logotype for Equillium Inc
Q4 202523 Mar, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Equillium earnings date

Logotype for Equillium Inc
Q4 202523 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Equillium Inc. is a clinical-stage biotechnology company that focuses on developing therapeutics for severe autoimmune and inflammatory disorders that have high unmet medical needs. It leverages a deep understanding of immunobiology to create novel treatments. Equillium's pipeline includes innovative, first-in-class immunomodulatory assets targeting critical immuno-inflammatory pathways. It is headquartered in La Jolla, California, and its shares are listed on the Nasdaq.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage